Clinical Trial Update: Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGD [EARLY_Phase 1]

View source ↗

Summary

An early phase 1 clinical trial is investigating diagnosis of metastatic tumors using 68Ga-FAPI-RGD PET-CT and radioligand therapy with 177Lu-FAPI-RGD, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 177Lu-FAPI-RGD
• 68Ga-FAPI-RGD

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: FAP- Expressing Positive Tumors, RGD- Expressing Positive Tumors | EARLY_Phase 1 | Status: RECRUITING